METACARE CO., Ltd. (KRX:118000)
South Korea · Delayed Price · Currency is KRW 1,321.00
+26.00 (2.01%)
Jul 21, 2026, 3:30 PM KST
METACARE CO. Market Cap
METACARE CO. has a market cap or net worth of 22.69 billion as of July 21, 2026. Its market cap has decreased by -61.60% in one year.
Market Cap
22.69B
Enterprise Value
74.11B
Revenue
36.95B
Ranking
n/a
PE Ratio
24.35
Stock Price
1,321.00
ChartMarket Cap Chart
Since January 4, 2010, METACARE CO.'s market cap has decreased from 39.82B to 22.69B, a decrease of -43.01%. That is a compound annual growth rate of -3.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 22.69B | -56.69% |
| Dec 30, 2025 | 52.39B | 12.75% |
| Dec 30, 2024 | 46.47B | -18.64% |
| Dec 28, 2023 | 57.11B | 29.66% |
| Dec 29, 2022 | 44.05B | -64.01% |
| Dec 30, 2021 | 122.39B | -14.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 62.26T |
| Celltrion | 39.58T |
| ALTEOGEN | 14.44T |
| Samsung Epis Holdings | 9.27T |
| Cellid, | 31.60B |
| Tdspharm | 30.47B |
| Aprogen Biologics | 26.09B |
| LAMEDITECH | 24.96B |